mortality/aging
• about 40% die before 18 months of age due to large pituitary tumors
|
neoplasm
• 10% incidence of pheochromocytomas
|
• most large pituitary tumors are chromophobe adenomas of the pars intermedia
|
• low incidence of thymic lymphoma
|
• 12% incidence of testicular neoplasia
|
• low incidence of B-cell lymphoma
|
• low incidence of renal cell carcinoma
|
• low incidence of angiosarcoma
|
endocrine/exocrine glands
• 10% incidence of pheochromocytomas
|
• seen as early as 6 months of age
|
• most large pituitary tumors are chromophobe adenomas of the pars intermedia
|
• low incidence of thymic lymphoma
|
• cysts in the galactophor ducts of the mammary epithelium at 12 weeks of age
|
• failure to differentiate, not associated with abnormal levels of luteinizing hormone (LH)
|
• 12% incidence of testicular neoplasia
|
growth/size/body
kidney cyst
(
J:63299
)
• tubular and glomerular cysts
|
• weight about 20% more than wild-type mice
|
• evident after 6 months of age
|
hematopoietic system
• low incidence of thymic lymphoma
|
• evident after 6 months of age
|
• cellular expansion of the white pulp
|
immune system
• low incidence of thymic lymphoma
|
• evident after 6 months of age
|
• cellular expansion of the white pulp
|
• cellular expansion of plasma cells in the medulla
|
• lymphoproliferative expansion, most often seen in the kidneys, lung, liver, and salivary glands
|
nervous system
• GNPs from mutants show ~50% levels of proliferation compared to Cdkn2c, Trp53-double null cells after 3 days in culture and levels of cells incorporating BrdU are still less in single mutants in tests where cells are stimulated with Shh after culture
|
• presence of these aberrant foci cerebellar molecular layer in mutants indicates a migration defect
|
• seen as early as 6 months of age
|
• most large pituitary tumors are chromophobe adenomas of the pars intermedia
|
• when irradiated mice are sacrificed at 6 months of age, all mice have abnormal microscopic foci of neuronal cells that are positive for GABA(A) alpha6 receptor subunit, a marker of differentiated, post-mitotic granule neurons which is not seen in granule neuronal precursor cells; these cells are not proliferating
• when mice are exposed to 4 Gy at P5 and sacrificed at P30, all show ~3-fold more neuronal foci (neuronal nests) located more deeply in the molecular layer compared to few detected accumulating at the external surface of the molecular layer in treated wild type
|
reproductive system
• failure to differentiate, not associated with abnormal levels of luteinizing hormone (LH)
|
• 12% incidence of testicular neoplasia
|
renal/urinary system
kidney cyst
(
J:63299
)
• tubular and glomerular cysts
|
• low incidence of renal cell carcinoma
|
• about 30% of mutants show cortical glomerulopathies after 9 months of age
• atropic glomeruli and glomerular cysts are sometimes seen
|
cellular
• increased germ cell apoptosis
|
• GNPs from mutants show ~50% levels of proliferation compared to Cdkn2c, Trp53-double null cells after 3 days in culture and levels of cells incorporating BrdU are still less in single mutants in tests where cells are stimulated with Shh after culture
|
• presence of these aberrant foci cerebellar molecular layer in mutants indicates a migration defect
|
homeostasis/metabolism
• ~75% reduction in levels relative to wild-type
• associated with a failure of leydig cell differentiation
|
integument
• cysts in the galactophor ducts of the mammary epithelium at 12 weeks of age
|